Ceftazidime shortage status
1 active shortage notice across 1 country.
Last updated 2 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Ceftazidime
- Brand names
- Juno, Tazicef
- ATC code
- J01DD02
- Class
- Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper
Where Ceftazidime is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | medium | 1 | 14 Nov 2025 | — | FDA |
Why Ceftazidime is in shortage
- product discontinuation — e.g. “Discontinuation of the manufacture of the drug” (United States)
Frequently asked questions
Is Ceftazidime currently in shortage?
Yes. As of the latest regulator updates, Ceftazidime has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Ceftazidime in shortage?
Regulators attribute the current Ceftazidime shortages to product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Ceftazidime shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Related medicines
Ceftriaxone · Cefotaxime · Ceftazidime-Pentahydrate · Cefepime Hydrochloride · Cefprozil · Cefuroxime
Get alerted when Ceftazidime status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.